Pulmonary hypertension: From molecular pathophysiology to haemodynamic abnormalities

被引:5
|
作者
Duong-Quy, S. [1 ]
Riviere, S. [1 ]
Bei, Y. [1 ]
Duong-Ngo, C. [1 ]
Le-Dong, N. N. [1 ]
Hua-Huy, T. [1 ]
Dinh-Xuan, A. T. [1 ]
机构
[1] Univ Paris 05, Serv Physiol, Hop Cochin, UPRES EA 2511,Fac Med, F-75104 Paris, France
关键词
Pulmonary hypertension; Pulmonary arterial hypertension; Physiopathology; Haemodynamic; Molecular pathology; VASOACTIVE-INTESTINAL-PEPTIDE; RHO-KINASE INHIBITOR; SMOOTH-MUSCLE-CELLS; 5-HYDROXYTRYPTAMINE TRANSPORTER GENE; SERINE ELASTASE INHIBITOR; CONGENITAL HEART-DISEASE; NITRIC-OXIDE SYNTHASE; ARTERIAL-HYPERTENSION; TENASCIN-C; TRANSGENIC MICE;
D O I
10.1016/j.rmr.2012.03.009
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Pulmonary hypertension (PH) is a complex disorder resulting from many etiologies that cause disturbances of normal pulmonary haemodynamics. Recent breakthroughs have led to a better understanding of the pathophysiology of the disease. In PH, haemodynamic disturbances are closely linked to structural changes and excessive remodeling of pulmonary vessels, leading to progressive narrowing of the pulmonary vascular lumen. Imbalances between pulmonary vasoconstrictors and vasodilators on the one hand, and factors favoring cell proliferation and apoptosis on the other hand, probably account for most cases of PH. This review aims to update readers with the current knowledge on the molecular physiopathology of PH and how this can progress the therapeutic of this disorder. (C) 2012 SPLF. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:956 / 970
页数:15
相关论文
共 50 条
  • [31] Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies
    Adu-Amankwaah, Joseph
    You, Qiang
    Liu, Xiaoer
    Jiang, Jiayi
    Yang, Dongqi
    Liu, Kuntao
    Yuan, Jinxiang
    Wang, Yanfang
    Hu, Qinghua
    Tan, Rubin
    MEDCOMM, 2025, 6 (03):
  • [32] Pathophysiology of Pulmonary Hypertension in Chronic Parenchymal Lung Disease
    Singh, Inderjit
    Ma, Kevin Cong
    Berlin, David Adam
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (04) : 366 - 371
  • [33] Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension
    Douwes, Johannes M.
    Roofthooft, Marcus T. R.
    Bartelds, Beatrijs
    Talsma, Melle D.
    Hillege, Hans L.
    Berger, Rolf M. F.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 1370 - 1377
  • [34] Haemodynamic unloading reverses occlusive vascular lesions in severe pulmonary hypertension
    Abe, Kohtaro
    Shinoda, Masako
    Tanaka, Mariko
    Kuwabara, Yukimitsu
    Yoshida, Keimei
    Hirooka, Yoshitaka
    McMurtry, Ivan F.
    Oka, Masahiko
    Sunagawa, Kenji
    CARDIOVASCULAR RESEARCH, 2016, 111 (01) : 16 - 25
  • [35] Group 2 Pulmonary Hypertension: Pulmonary Venous Hypertension: Epidemiology and Pathophysiology
    Clark, Craig B.
    Horn, Evelyn M.
    CARDIOLOGY CLINICS, 2016, 34 (03) : 401 - +
  • [36] Cardiac Arrhythmias in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Mechanistic Insights, Pathophysiology, and Outcomes
    Abouzaid, Abdulrahman
    Ali, Khansa
    Jatoi, Suniya
    Ahmed, Mansoor
    Ahmad, Gulfam
    Nazim, Ahsan
    Mehmoodi, Amin
    Malik, Jahanzeb
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2024, 29 (05)
  • [37] Lessons from lung transplantation: Cause for redefining the pathophysiology of pulmonary hypertension in gaucher disease
    Goobie, Gillian C.
    Sirrs, Sandra M.
    Yee, John
    English, John C.
    Bergeron, Celine
    Nador, Roland
    Swiston, John R.
    Mistry, Pramod K.
    Paquin, Wendy
    Levy, Robert D.
    RESPIRATORY MEDICINE CASE REPORTS, 2019, 28
  • [38] Pathophysiology and treatment of pulmonary arterial hypertension
    Humbert, M.
    Boucly, A.
    Guignabert, C.
    Savale, L.
    Sitbon, O.
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2023, 207 (01):
  • [39] New Drugs and Therapies in Pulmonary Arterial Hypertension
    Shah, Aangi J.
    Beckmann, Taylor
    Vorla, Mounica
    Kalra, Dinesh K.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [40] Molecular Pathophysiology of Portal Hypertension
    Fernandez, Mercedes
    HEPATOLOGY, 2015, 61 (04) : 1406 - 1415